FASLG and neoplasm: To evaluate if the enhanced proliferation of TCR1045/Fas-4-1BBtm T cells is due to FasL signaling from tumor cells and/or T cells, T cells were treated with Cell Trace Violet and co-cultured with wild type or E9 ID8VEGFFasL-/- tumor cells for 7 days.